New collaboration to have broad impact on diabetes, insulin management for leading academic health system in South Carolina
Glytec, the Software-as-a-Service (SaaS) technology leader and pioneer in diabetes and insulin management, is proud to announce a collaboration with MUSC Health, the clinical enterprise of the Medical University of South Carolina (MUSC), the state’s only comprehensive academic health system. This collaboration is set to transform diabetes and glycemic management across MUSC’s hospital network, improving patient safety, clinical outcomes and overall health care efficiency.
With over 37 million Americans currently diagnosed with either Type 1 or Type 2 diabetes, and many more at risk, Glytec’s technology marks a major advancement in managing this widespread condition. More than one-third of hospitalized patients require insulin therapy, underscoring the need for effective software to manage workflows and patient care – now further emphasized by new Centers for Medicare and Medicaid Services (CMS) hospital glycemia reporting mandates.
MUSC’s leadership team and Information Technology experts conducted a comprehensive evaluation of available diabetes and insulin management solutions and selected Glytec for its ability to integrate with the health system’s existing electronic medical record (EMR) system, EPIC. Glytec’s platform will provide advanced clinical decision support, streamline insulin therapy and reduce variability in glycemic management, ultimately helping clinicians to make more informed decisions and ultimately improve patient outcomes.
“Our collaboration with Glytec marks a significant milestone in our ongoing efforts to enhance diabetes care across MUSC,” said Danielle Scheurer, M.D., chief quality officer at MUSC Health. “By integrating Glytec’s insulin management system with our EMR, we can ensure a more effective, data-driven approach to managing inpatient and outpatient diabetes care, improving workflows for our clinical teams and delivering better results for our patients.”
With a mission to deliver high-quality care and innovative treatment solutions, MUSC is dedicated to advancing diabetes management and addressing the complexities of glycemic control. This relationship will enable MUSC Health’s hospitals to utilize Glytec’s FDA-cleared software to ensure that all clinical settings across the system are fully prepared to meet the new CMS requirements.
“We are excited to collaborate with MUSC and to support their commitment to innovation in diabetes care,” said Patrick Cua, CEO of Glytec. “Our software will help MUSC clinicians provide personalized, cost-effective care to a meaningful percentage of patients, providing them and their families with access to the leading platform in diabetes safety and outcomes.”
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!